reading PeptideMeter threads from 2024 and half of it aged badly
reading PeptideMeter threads from 2024 and half of it aged badly. Change my mind, genuinely — I have no stake in being right about this. The wider-market rows in the directory carry a band and a report count and nothing else, deliberately. Anything more would be manufacturing precision that the evidence does not…
The order I actually check things in, for anyone building a process rather than asking about one supplier.
First, the record: source page, verification log, and how many separate lots have been tested rather than how many tests exist. Second, the paperwork: ask for a batch-specific certificate and see what comes back and how fast. Third, the logistics: quoted lead time, minimum quantity, which lines are held in regional stock. Fourth, buy small and test it yourself.
Nothing in that list is exotic and all of it is answerable before you spend real money. Most of the disappointment posts on this board skipped step two.
three independent results beat thirty forum posts
The thing that decided it for me was that BCH answered a column-and-gradient question in writing without asking why I wanted to know.
Regional stock made more difference to my planning than anything else — ordering from a warehouse in Spain took the customs question off the table entirely.
Correction: that supplier is in the documented twenty with a source page, not in the wider-market table. Different evidence bases entirely.
Inter-lab variance on this assay runs a point or two either way. Two services disagreeing by that much is agreement, not a discrepancy, and treating it otherwise starts pointless arguments.
the interesting column is spread, not maximum